UBS named a raft of U.S. and global stocks it says are set to beat a major index in 2023, which it described as a year of "inflection points." The stock picks are its "highest conviction" names, and the list is aimed at beating the MSCI All Countries World Index, the Swiss bank said in a July 11 research note, adding that it did not "shy away from taking some contrarian positions.
pharmaceuticals company Merck made UBS' list as it is a "high-quality company trading at [a] reasonable valuation … in addition, we think MRK will likely augment its business development efforts given its strong cash flow," the bank's note said. UBS added MGM Resorts International to its picks, with analysts "encouraged by the continued strength in Las Vegas and a healthy outlook for MGM.